oPatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.
Synonyms: oral herpes labialis, cold sore
Herpes simplex virus type 1 (HSV-1) is usually the cause of oral infection. After primary infection, HSV-1 becomes latent, usually in the dorsal root ganglia of the trigeminal nerve. Rarely, herpes simplex virus type 2 (HSV-2) may cause primary infection of the oral cavity, typically in association with orogenital sex, but recurrent oral HSV-2 disease is rare.
- About 1% of primary care consultations are for cold sores.
- 56-85% of people have serological evidence of HSV-1 infection by early adulthood. Prevalence depends on their resident country.
- 20-40% of young adults who are seropositive for HSV-1 have recurrent cold sores.
- Recurrences occur typically between two and six times a year.
- A study from Amsterdam found that HSV-1 seroprevalence varied according to ethnicity and was more prevlalent in older age groups and those of low economic status.
- Transmission is due to viral shedding into saliva and can occur by direct contact with saliva (eg, kissing). Viral shedding into saliva may occur during asymptomatic infection but it is thought that the risk of infection is much smaller than during symptomatic infection.
- Viral shedding can occur up to 60 hours after the onset of symptoms.
- Factors that may trigger a recurrence of oral herpes simplex include immunosuppression (eg, corticosteroids), upper respiratory tract infections, fatigue, emotional stress, physical trauma, exposure to sun (ultraviolet light), trauma and menstruation.
- Obesity may increase susceptibility to HSV-1 infection.
Infection with HSV can cause pain and blistering within the mouth (gingivostomatitis or recurrent oral ulceration) or on or around the lips (cold sores or herpes labialis).
- Primary infection:
- This occurs most often in infancy or childhood. It may or may not be symptomatic.
- Gingivostomatitis is the most common presentation in young children. It presents with vesicles and ulcers on the tongue, lips, gums, buccal mucosa and hard and soft palates. Pain, inability to swallow, drooling and dehydration are common. There may be associated fever, cervical lymphadenopathy, halitosis, lethargy, loss of appetite and irritability.
- Pharyngitis is a more common presentation in adolescents, with lesions in the throat associated with viral symptoms similar to those of glandular fever.
- Herpetic whitlow may occasionally occur via spread to the fingers.
- Recurrent infection:
- Cold sore lesions are the most common form of recurrent disease. They tend to occur in the same location, be unilateral and recur two or three times a year on average.
- Prodromal symptoms may occur 6-24 hours before the appearance of a lesion and include tingling, pain and/or itching in the perioral area.
- Cold sores are usually seen on the lips and extend to the skin around the mouth. Other areas on the face, chin, or nose are sometimes involved. Lesions begin as erythematous areas that swell into papules. These become vesicles, which then collapse into ulcers. This takes 1-3 days. The ulcers crust over and the skin returns to normal within about two weeks.
- Oral mucosal lesions are rare and not generally associated with fever. They are usually restricted to small clusters of microvesicles that rupture to leave punctate ulcers, typically on the palatal gingiva. Immunocompromised people may develop chronic ulcers, often on the tongue.
- Differential diagnosis of herpes simplex gingivostomatitis:
- Aphthous ulcers - do not cause fever and lesions are more likely to be on non-keratinised mucosa.
- Hand, foot and mouth disease - lesions may also be seen on the hands or feet.
- Herpes zoster of the second or third division of the trigeminal nerve.
- Infectious mononucleosis.
- Erythema multiforme.
- Stevens-Johnson syndrome.
- Behçet's disease.
- Differential diagnosis of cold sores:
- Signs of possible oral cancer include:
- Ulceration of the oral mucosa persisting for more than three weeks.
- Oral swellings persisting for more than three weeks.
- All red or red and white patches of the oral mucosa.
- The level of suspicion is further increased if the person is a heavy smoker, heavy alcohol drinker, aged over 45 years or male.
- The National Institute for Health and Care Excellence (NICE) guidance on referral for suspected cancer recommends urgent referral for a person with:
- Unexplained red and white patches (including suspected lichen planus) of the oral mucosa that are painful, or swollen, or bleeding.
- Unexplained ulceration of the oral mucosa, or mass persisting for more than three weeks.
- NICE also recommends that any person with persistent oral symptoms or signs in whom a definite diagnosis of a benign lesion cannot be made should be referred or followed up until the symptoms and signs disappear. If the symptoms and signs have not disappeared after six weeks, an urgent referral should be made.
- Tests are not usually necessary in immunocompetent people, as history and examination will usually confirm the diagnosis.
- Viral culture from swabs of lesions has been considered the gold standard but is limited by the short time period of viral shedding and the relatively low number of viral particles present in samples. Also, positives increase 48 hours after the lesions have appeared.
- Rapid detection based on polymerase chain reaction (PCR) is available when required (eg, immunocompromised patients, severe infection).
- Cold sores or gingivostomatitis is usually mild and self-limiting and so can be managed symptomatically. Reassure the patient that lesions will heal without scarring.
- A soft diet may be needed: drinking should also be encouraged to prevent dehydration.
- Give advice to reduce the risk of transmission:
- Avoid touching the lesions.
- Wash hands with soap and water immediately after touching the lesions, such as after applying medication.
- Topical medications should be dabbed on rather than rubbed in, to minimise trauma.
- Topical medications or other items that come into contact with a lesion area - eg, lipstick or lip gloss - should not be shared with others.
- Avoid kissing until the lesions have completely healed.
- Avoid oral sex until all lesions have completely healed.
- There is a risk of transmission to the eye if contact lenses become contaminated.
- Children with cold sores do not need to be excluded from nurseries and schools.
- Advise to seek medical advice if the person's condition deteriorates (eg, the lesion spreads, a new lesions develops after the initial outbreak, persistent fever, inability to eat) or no improvement is seen after 7-10 days.
- Paracetamol and ibuprofen are effective in relieving pain and pyrexia.
- Local analgesic for gingivostomatitis - benzydamine mouthwash (over 13 years) or spray (no age restriction but different doses above and below the age of 6).
- Chlorhexidine mouthwash for gingivostomatitis (age range not specified by the manufacturer).
- Choline salicylate gel for pain control of cold sores (this is contra-indicated under the age of 16 due to Reye's syndrome).
- Lidocaine gel for pain control of cold sores (there is no age restriction specified in the British National Formulary for Children).
- Topical antiviral agents:
- Aciclovir 5% (age range is not specified by the manufacturer).
- Penciclovir 1% cream should be used from the age of 12.
- The benefits of topical antivirals are small and cold sores usually resolve within 7-10 days even without treatment.
- Topical antivirals do not prevent future episodes of cold sores alone but studies have found that a combination of 5% aciclovir and 1% hydrocortisone showed some preventative activity.
- Treatment needs to be initiated at the onset of symptoms before vesicles appear.
- Topical antivirals need to be applied frequently for a minimum of 4-5 days.
- Oral antiviral agents:
- For immunocompetent individuals, oral antivirals are not routinely indicated for the treatment of cold sores but may be indicated in severe episodes.
- Seek specialist advice for people who are immunocompromised (including people with HIV).
- Aciclovir is active against herpes viruses but does not eradicate them. It can be used as systemic and topical treatment of herpes simplex infections of the mucous membranes and is used orally for severe herpetic stomatitis.
- Valaciclovir is an ester of aciclovir. It is licensed for herpes simplex infections of the skin and mucous membranes.
Laser therapy decreases pain and reduces the number of recurrences. It is particularly useful for elderly patients, due to the low frequency of side effects. However, large-scale double-blind trials have not yet been conducted.
- Seek advice for managing immunocompromised individuals who have cold sores, including people with HIV.
- Seek specialist advice if neonatal herpes is suspected (this is rare; it may present with skin, eye and/or mouth symptoms).
- Dehydration, especially in children.
- Recurrent lesions at the same site may occasionally cause atrophy and scarring.
- Secondary bacterial infection, including impetigo, can occur.
- Eczema herpeticum can complicate atopic eczema.
- Bell's palsy is possibly a complication of herpes simplex infection.
- Rare complications include dissemination, herpes encephalitis, meningitis, corneal dendritic ulcers (ocular herpes simplex) and erythema multiforme.
- Oral herpes simplex is usually a self-limiting disease.
- Lesions (whether due to primary infection or recurrent disease) usually heal within 7-10 days, without scarring.
- Sunscreen may be useful for people who have recurrences triggered by sunlight but the evidence is equivocal.
- There is some evidence that application of a topical antiviral before exposure to a triggering factor (eg, sunlight) offers some protection.
- Prophylactic oral antivirals are not generally recommended for immunocompetent individuals. There is support for the use of systemic aciclovir and valaciclovir for the prevention of recurrent attacks and this is an appropriate prophylaxis for people with frequent or severe episodes, or for immunocompromised individuals (specialist advice should be sought).
- Laser phototherapy may help to reduce the frequency of attacks in recurrent herpes labialis.
Further reading & references
- Vogel JL, Kristie TM; The dynamics of HCF-1 modulation of herpes simplex virus chromatin during initiation of infection. Viruses. 2013 May 22;5(5):1272-91. doi: 10.3390/v5051272.
- Cunningham A, Griffiths P, Leone P, et al; Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol. 2012 Jan;53(1):6-11. doi: 10.1016/j.jcv.2011.08.003. Epub 2011 Sep 1.
- St Pierre SA, Bartlett BL, Schlosser BJ; Practical management measures for patients with recurrent herpes labialis. Skin Therapy Lett. 2009 Nov-Dec;14(8):1-3.
- Herpes simplex - oral; NICE CKS, Sept 2012
- Kramer M et al; Ethnic differences in HSV1 and HSV2. Eurosurveillance, Volume 13, Issue 24, 12 June 2008.
- Karjala Z, Neal D, Rohrer J; Association between HSV1 seropositivity and obesity: data from the National Health and Nutritional Examination Survey, 2007-2008. PLoS One. 2011 May 11;6(5):e19092. doi: 10.1371/journal.pone.0019092.
- Referral for suspected cancer, NICE Clinical Guideline (2005)
- Gitman MR, Ferguson D, Landry ML; Comparison of Simplexa HSV 1 & 2 Direct PCR with Culture, Immunofluorescence and Laboratory Developed TaqMan PCR for Detection of Herpes Simplex Virus in Swab Specimens. J Clin Microbiol. 2013 Sep 4.
- British National Formulary for Children; British Medical Association and Royal Pharmaceutical Society of Great Britain. London
- Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid; Prescrire Int. 2011 Sep;20(119):205-7.
- de Paula Eduardo C, Aranha AC, Simoes A, et al; Laser treatment of recurrent herpes labialis: a literature review. Lasers Med Sci. 2013 Apr 13.
- Opstelten W, Neven AK, Eekhof J; Treatment and prevention of herpes labialis. Can Fam Physician. 2008 Dec;54(12):1683-7.
- Rahimi H, Mara T, Costella J, et al; Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 May;113(5):618-27. doi: 10.1016/j.oooo.2011.10.010. Epub 2012 Apr 12.
- Munoz Sanchez PJ, Capote Femenias JL, Diaz Tejeda A, et al; The effect of 670-nm low laser therapy on herpes simplex type 1. Photomed Laser Surg. 2012 Jan;30(1):37-40. doi: 10.1089/pho.2011.3076. Epub 2011 Nov 2.
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.
|Original Author: Dr Colin Tidy||Current Version: Dr Laurence Knott||Peer Reviewer: Prof Cathy Jackson|
|Last Checked: 15/10/2013||Document ID: 2258 Version: 28||© EMIS|